161 related articles for article (PubMed ID: 15158344)
21. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
Kamar N; Boulestin A; Selves J; Esposito L; Sandres-Saune K; Stébenet M; Chatelut E; Durand D; Rostaing L; Izopet J
J Med Virol; 2005 May; 76(1):61-8. PubMed ID: 15778976
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K
Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025
[TBL] [Abstract][Full Text] [Related]
23. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
24. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
[TBL] [Abstract][Full Text] [Related]
25. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
[TBL] [Abstract][Full Text] [Related]
26. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection.
Distante S; Bjøro K; Hellum KB; Myrvang B; Berg JP; Skaug K; Raknerud N; Bell H
Liver; 2002 Jun; 22(3):269-75. PubMed ID: 12100578
[TBL] [Abstract][Full Text] [Related]
27. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of chronic hepatitis C in patients without previous treatment].
Dehesa Violante M
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
[TBL] [Abstract][Full Text] [Related]
29. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
Pianko S; McHutchison JG; Gordon SC; Heaton S; Goodman ZD; Patel K; Cortese CM; Brunt EM; Bacon BR; Blatt LM
J Interferon Cytokine Res; 2002 Apr; 22(4):483-9. PubMed ID: 12034031
[TBL] [Abstract][Full Text] [Related]
30. Iron overload in patients with chronic viral hepatitis: how common is it?
Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
[TBL] [Abstract][Full Text] [Related]
31. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.
Carneiro MV; Souza FF; Teixeira AC; Figueiredo JF; Villanova MG; Secaf M; Passos AD; Ramalho LN; Carneiro FP; Zucoloto S; Candolo Martinelli AL
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1204-10. PubMed ID: 20555268
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
33. Iron in hepatitis C: villain or innocent bystander?
Ioannou GN; Tung BY; Kowdley KV
Semin Gastrointest Dis; 2002 Apr; 13(2):95-108. PubMed ID: 12064865
[TBL] [Abstract][Full Text] [Related]
34. Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy.
Neuman MG; Benhamou JP; Ibrahim A; Malkiewicz I; Spircu T; Martinot-Peignoux M; Shear NH; Katz GG; Akremi R; Bourliere M; Marcellin P
Rom J Gastroenterol; 2002 Jun; 11(2):97-103. PubMed ID: 12145664
[TBL] [Abstract][Full Text] [Related]
35. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
[TBL] [Abstract][Full Text] [Related]
36. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C.
Kageyama F; Kobayashi Y; Murohisa G; Shimizu E; Suzuki F; Kikuyama M; Souda K; Kawasaki T; Nakamura H
Biol Trace Elem Res; 1998; 64(1-3):185-96. PubMed ID: 9845473
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical and histologic changes in patients with chronic hepatitis C under treatment with interferon. a 5-year cohort study].
Dávila-Fernández BC; Santiago-Luna E; Navarro-López R; Moreno Villa HR; Cumplido-Hernández G
Rev Gastroenterol Mex; 2003; 68(1):16-22. PubMed ID: 12940094
[TBL] [Abstract][Full Text] [Related]
38. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
Cagnoni C; Corsini F; Pancotti D; Carrara G
Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
[TBL] [Abstract][Full Text] [Related]
39. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
[TBL] [Abstract][Full Text] [Related]
40. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
